Abciximab Completed Phase 4 Trials for Acute Coronary Syndrome (ACS) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00929279Efficacy of Abciximab Bolus Only Regimen in Providing Inhibition of Platelet Action Over Time